INFLUENZA A VIRUS IGM ANTIBODY

The INFLUENZA A VIRUS IgM Antibody test detects IgM-class antibodies against Influenza A virus in a patient’s blood, indicating a recent or acute immune response to infection. This at‑home collection service is processed by Dubai‑ and UAE‑certified laboratories, providing timely results that help identify recent exposure when molecular testing is not available or as a complementary diagnostic tool.

This test is useful for individuals who develop flu‑like symptoms (fever, cough, sore throat) or who have had a known exposure to a confirmed case and need evidence of recent infection. Note that IgM antibody detection reflects immune response rather than direct viral presence—reverse transcription PCR (RT‑PCR) remains the standard for confirming active viral shedding and infectivity—so clinicians may request combined testing or follow‑up PCR depending on clinical needs.

Sample collection is performed at home by a trained phlebotomist (venous blood or capillary sample as specified by the lab); no fasting is required. Results are reported through secure channels (email/SMS/online portal) within the turnaround time provided at booking; interpretation should be made by a healthcare professional because recent vaccination, prior immunity, or cross‑reactivity can affect results.

• Influenza A IgM antibody
• IgM index / semi‑quantitative titer (if reported)
• Qualitative result (Reactive / Non‑reactive)
• Sample type: Serum / Plasma

• Onset of flu‑like symptoms (fever, cough, sore throat)
• 3–7 days after suspected exposure to a confirmed Influenza A case
• When PCR testing is unavailable or as a complementary serologic assessment
• Prior to visiting high‑risk individuals (elderly, infants, immunocompromised)
• During local influenza outbreaks or seasonal surge in the UAE

• Early indication of recent Influenza A infection
• Convenient at‑home sample collection across Dubai and the UAE
• Processing in accredited, certified laboratories for reliable reporting
• Fast electronic delivery of results to support timely clinical decisions
• Useful for public‑health follow‑up and clinical management when combined with clinical assessment

• At‑home blood sample collection by a certified phlebotomist (venous or finger‑prick)
• No fasting required prior to sample collection
• Provide valid Emirates ID and accurate contact details for report delivery
• Inform the phlebotomist/lab of recent influenza vaccination, immunoglobulin therapy, or immunosuppressive treatment